ReviewNature reviews. Drug discovery2004
Fluorescent probes for proteolysis: tools for drug discovery.
Review in Nature reviews. Drug discovery, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Extracellularly Activatable Conjugates of RGD Peptidomimetics and Cryptophycin for αChemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Mitochondria serve as a holdout compartment for aggregation-prone proteins hindering efficient degradation.Nature communications · 2026Article
- Mechanism and Kinetics of HIV-1 Protease Activation.Viruses · 2024Review
- On-demand expansion fluorescence and photoacoustic microscopy (ExFLPAM).Photoacoustics · 2024Article
- Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency.Human molecular genetics · 2024Article
- Fluctuation of lysosomal protein degradation in neural stem cells of the postnatal mouse brain.Development (Cambridge, England) · 2024Article
- Article
- Embracing enzyme promiscuity with activity-based compressed biosensing.Cell reports methods · 2023Article
- A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia.Journal of medicinal chemistry · 2022Article
- The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.Cellular and molecular life sciences : CMLS · 2022Article
- Enzyme assays with supramolecular chemosensors - the label-free approach.RSC advances · 2022Review
- Universal Access to Protease Chemiluminescent Probes through Solid-Phase Synthesis.Bioconjugate chemistry · 2021Article
- High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses.Molecules (Basel, Switzerland) · 2021Article
- Reporter-Based Screens for the Ubiquitin/Proteasome System.Frontiers in chemistry · 2020Review
- Stepwise triple-click functionalization of synthetic peptides.Organic & biomolecular chemistry · 2018Article
- Caspase-3/-7-Specific Metabolic Precursor for Bioorthogonal Tracking of Tumor Apoptosis.Scientific reports · 2017Article
- Cancer with low cathepsin D levels is susceptible to vacuolar (HCancer science · 2017Article
- Mask mitigates MAPT- and FUS-induced degeneration by enhancing autophagy through lysosomal acidification.Autophagy · 2017Article
- GPU accelerated real-time confocal fluorescence lifetime imaging microscopy (FLIM) based on the analog mean-delay (AMD) method.Biomedical optics express · 2016Article
- Protein sensing in living cells by molecular rotor-based fluorescence-switchable chemical probes.Chemical science · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.